Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
暂无分享,去创建一个
Michael D. Robbins | D. Chao | G. Starling | A. Rice | Rui Yun | M. Fox | N. Belmar | B. Balasa
暂无分享,去创建一个
Michael D. Robbins | D. Chao | G. Starling | A. Rice | Rui Yun | M. Fox | N. Belmar | B. Balasa